سعر اتروفنت Atrovent‏ 250مكجم/2مل 20 فيال جلسات البخار 2026

Atrovent (ipratropium bromide) 250 micrograms/2 ml nebuliser solution, 20 unit-dose vials (Boehringer Ingelheim).

• Most frequent: headache, throat irritation, cough, dry mouth, gastrointestinal motility disorders, nausea and dizziness; uncommon: blurred vision, mydriasis, raised intraocular pressure, palpitations, supraventricular tachycardia, urinary retention, rash.International label, equivalent formulation · electronic Medicines Compendium (eMC), MHRA-authorised

• Known hypersensitivity to atropine or its derivatives (including ipratropium bromide) or to any other component.International label, equivalent formulation · electronic Medicines Compendium (eMC), MHRA-authorised

• Immediate hypersensitivity (urticaria, angioedema, bronchospasm, anaphylaxis); paradoxical bronchospasm (stop and treat); ocular complications and narrow-angle glaucoma if the mist contacts the eyes; caution in urinary outflow obstruction and in cystic fibrosis (GI motility).International label, equivalent formulation · electronic Medicines Compendium (eMC), MHRA-authorised

• Other anticholinergic drugsChronic co-administration not studied and not recommended.electronic Medicines Compendium (eMC), MHRA-authorised
• Beta-adrenergic agents and xanthinesMay produce an additive bronchodilator effect; with nebulised beta2-agonists the risk of acute glaucoma may increase in patients with a history of narrow-angle glaucoma.electronic Medicines Compendium (eMC), MHRA-authorised

• Safety in human pregnancy not established; weigh benefits against possible hazards. Nonclinical studies showed no embryotoxic or teratogenic effects at doses well above human doses.International label, equivalent formulation · electronic Medicines Compendium (eMC), MHRA-authorised
• Unknown whether excreted in breast milk; unlikely to reach the infant to an important extent, but use caution in nursing mothers.International label, equivalent formulation · electronic Medicines Compendium (eMC), MHRA-authorised

• Ipratropium bromide: Blocks muscarinic receptors in bronchial smooth muscle, reducing vagally mediated bronchoconstriction; minimal systemic absorption when inhaled.